GlassScriptPhysician profile
Timothy Robert Malinowski
NPI 1740893593
$49,470.91
in general payments reported to CMS, 2019-2025
28 companies · $43K in 2025
The $43K reported for 2025 was more than what 99% of Gerontology (Nurse Practitioner) providers received nationally (typical 2025 total: $180).
See the full distribution for Gerontology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $886 · 2022: $1,065 · 2023: $1,367 · 2024: $3,183 · 2025: $43K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $29K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $6,500 · Food and Beverage: $6,310 · Travel and Lodging: $5,854.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $28,856.25 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $6,500.00 |
| Food and Beverage | $6,310.11 |
| Travel and Lodging | $5,853.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endotronix, INC. | $21,112.05 | 2024-2025 | Cordella Pulomonary Artery Pressure Sensor, Cordella Pulmonary Artery Pressure Sensor |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $15,506.82 | 2021-2025 | Lifevest |
| Edwards Lifesciences Corporation | $5,195.48 | 2021-2025 | |
| Analog Devices INC. | $1,250.00 | 2025 | Sensinel Cpm Wearable |
| Kestra Medical Technology Services, INC. | $974.70 | 2023-2025 | Assure Wcd |
| Novartis Pharmaceuticals Corporation | $885.97 | 2021-2025 | |
| Cvrx, INC. | $680.17 | 2022-2025 | Barostim Neo System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $462.61 | 2021-2025 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $446.03 | 2021-2025 | Farxiga, Wainua |
| Impulse Dynamics (USA) INC. | $358.70 | 2024-2025 | Optimizer |
| United Therapeutics Corporation | $293.66 | 2021-2025 | Tyvaso |
| Boston Scientific Corporation | $277.43 | 2022-2025 | Bodyguardian |
| Actelion Pharmaceuticals US, INC. | $270.16 | 2022-2025 | Uptravi, Opsumit |
| Abiomed | $264.38 | 2021-2025 | Impella |
| Abbott Laboratories | $258.74 | 2025 | Cardiomems, Thoratec Heartmate 3 Lvas Implant Kit |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scpharmaceuticals INC. | $219.75 | 2023-2025 | |
| Bridgebio Pharma, INC. | $191.54 | 2025 | Attruby |
| E.R. Squibb & Sons, L.L.C. | $179.04 | 2023-2024 | Camzyos, Eliquis |
| Alnylam Pharmaceuticals INC. | $139.19 | 2022-2025 | Onpattro |
| Merck Sharp & Dohme LLC | $118.50 | 2025 | Winrevair |
| Janssen Pharmaceuticals, INC | $85.82 | 2021 | |
| Amgen INC. | $85.40 | 2022-2024 | Repatha |
| Pfizer INC. | $65.18 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $60.33 | 2025 | |
| Daiichi Sankyo INC. | $43.55 | 2022-2023 | Injectafer |
| Lexicon Pharmaceuticals, INC. | $17.25 | 2024 | |
| Kiniksa Pharmaceuticals, LTD. | $15.63 | 2022 | |
| Medtronic, INC. | $12.83 | 2023 | Percepta Quad Crt-P Mri Surescan |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Malinowski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.